| Patient | Mary McLeod Bethune |
|---|---|
| Date of birth | 1953-07-10 |
| Identifiers | MRN HR-ML043-SYN; SSN (made up) 000-43-2195 |
| Document date | 2026-03-09 |
| Author | Viola Harrington-Mbeki, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for new patient visit for four months of wheeze, night cough and breathlessness on exertion in a 72-year-old woman with long-standing asthma that was never confirmed: examination, chest X-ray, ECG, blood tests and BNP, and planning of lung function testing and an echocardiogram. [S]
Hemoglobin: 12.9 g/dL; White cell count: 7.6 10*3/uL; Blood eosinophils: 0.42 10*3/uL; Platelets: 268 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.92 mg/dL; eGFR (CKD-EPI 2021): 66 mL/min/1.73 m²; Glucose: 102 mg/dL (high); Hemoglobin A1c: 5.9% (high); TSH: 2.2 mIU/L; BNP: 48 pg/mL; Total cholesterol: 228 mg/dL (high); HDL cholesterol: 56 mg/dL; Triglycerides: 140 mg/dL; LDL cholesterol: 144 mg/dL (high); Urine albumin-to-creatinine ratio: 18 mg/g; PHQ-2: 1; Asthma Control Test: 13. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-09 | Body height | 163 | cm | S |
| 2026-03-09 | Body weight | 88 | kg | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 33.1 | kg/m2 | S |
| 2026-03-09 | Systolic blood pressure | 152 | mm[Hg] | S |
| 2026-03-09 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 2026-03-09 | Heart rate | 82 | /min | S |
| 2026-03-09 | Respiratory rate | 20 | /min | S |
| 2026-03-09 | Body temperature | 36.7 | Cel | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-09 | Hemoglobin [Mass/volume] in Blood | 12.9 | g/dL | 12-15.5 g/dL | Normal | S |
| 2026-03-09 | Leukocytes [#/volume] in Blood by Automated count | 7.6 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-03-09 | Eosinophils [#/volume] in Blood by Automated count | 0.42 | 10*3/uL | 0-0.5 10*3/uL | Normal | S |
| 2026-03-09 | Platelets [#/volume] in Blood by Automated count | 268 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-03-09 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-09 | Potassium [Moles/volume] in Serum or Plasma | 4.1 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.92 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 66 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-09 | Glucose [Mass/volume] in Serum or Plasma | 102 | mg/dL | 70-99 mg/dL | High | S |
| 2026-03-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | % | Below 5.7% is normal; 5.7 to 6.4% prediabetes; 6.5% or more diabetes | High | S |
| 2026-03-09 | Thyrotropin [Units/volume] in Serum or Plasma | 2.2 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 2026-03-09 | Natriuretic peptide B [Mass/volume] in Serum or Plasma | 48 | pg/mL | Below 100 pg/mL makes heart failure unlikely | Normal | S |
| 2026-03-09 | Cholesterol [Mass/volume] in Serum or Plasma | 228 | mg/dL | <=199 mg/dL | High | S |
| 2026-03-09 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56 | mg/dL | 50 mg/dL or more for women | Normal | S |
| 2026-03-09 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-03-09 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 144 | mg/dL | <=99 mg/dL | High | S |
| 2026-03-09 | Albumin/Creatinine [Mass Ratio] in Urine | 18 | mg/g | <=30 mg/g | Normal | S |
| 2026-03-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S | ||
| 2026-03-09 | Total score [ACT] | 13 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid) | Two puffs every 4 hours as needed; she uses it most days | Respiratory tract route | 2025-11-03 to 2026-03-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram booked | active | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented chronic asthma. Superseded by the diagnosis at the second visit. |
| Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialist | active | confirmed | R09.81 | S — Synthetic upper-airway symptoms; superseded by the diagnosis of chronic rhinosinusitis after nasal endoscopy. |
| Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight loss | active | confirmed | K21.9 | S — Synthetic comorbidity of asthma; not a claim about her real health. |
| Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about it | active | confirmed | E66.811 | S — Synthetic comorbidity recorded in her words and with her agreement; not a claim about her real weight. |